Obermatt
See Similar Stocks →

Hisamitsu Pharmaceutical

TYO:4530 · JP3784600003
PharmaceuticalsLarge

360

61
Medium confidence — indicative
Profit price42
Cash yield1
Price/Sales32
Price/Book71
Return on Capital67
Cash Return on Capital67
Return on Equity69
EBIT Margin76
Gross Profitability61
Cash Conversion25
Accruals39
Owner Earnings Margin80
Sales growth64
Profit Growth29
Long-Term EPS Growth34
Reinvestment41
Price momentum79
Debt load93
Refinancing70
Debt Payback100
Liquidity98
Analyst ratings11
Opinion Changes2
Price Target Upside1
Market mood41
Value Creation10/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Hisamitsu Pharmaceutical clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Based on 3/5 components.

Profile

CountryJapan
IndustryPharmaceuticals
SizeLarge
TypePrivate Company
ExchangeOTCPK
Founded1944
Employees230
Websitehisamitsu.co.jp
ISINJP3784600003
Last UpdateApr 2, 2026
Index & Theme
Pain ManagementInflammationWomen's HealthRespiratoryBiotechnologyMedicalPharmaceutical

Description

Analysis

Middle-of-the-road

Hisamitsu Pharmaceutical Co., Inc. sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is attractive. The owner-earnings multiple stands at 3.4×; owner earnings: the cash an owner could take out each year.

Growth is moderate; the safety picture is sturdy. The company scores 10/20 on our value-creation score: creating some value. Analyst sentiment is cautious.

Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
55
2023202420252026

All-time high

93

Jan 2023

All-time low

55

Mar 2026

Average rank

79

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
32
37
45
56
Price/Earnings
40
49
47
58
Price/Book
71
64
67
72
Dividend Yield
1
56
55
60
Value (overall)
56
42
56
59

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Hisamitsu Pharmaceutical with its peers
PharmGen Science
KSC:004720
74
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Kukje Pharma
KSC:002720
43
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Chong Kun Dang
KSC:185750
55
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
GC Biopharma
KSC:006280
52
CountrySouth Korea
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Dongwha Pharm
KSC:000020
44
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Santen Pharmaceutical
TYO:4536
65
CountryJapan
IndustryPharmaceuticals
SizeLarge
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →